Evaluate the Safety, Immunologic, and Virologic Responses of Donor Derived (DD) HIV-Specific T-cells (HST) in HIV-infected Individuals Following Allogeneic Bone Marrow Transplantation (alloRESIST)

Condition:   HIV-Infected Individuals Intervention:   Biological: DD HST-NEETs Sponsor:   Catherine Bollard Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials